Related references
Note: Only part of the references are listed.Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)
T. VASSILEV et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Falk Nimmerjahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Intravenous immunoglobulin:: An update on the clinical use and mechanisms of action
Vir-Singh Negi et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade
Liming Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality
Bernard J. Scallon et al.
MOLECULAR IMMUNOLOGY (2007)
The antiinflammatory activity of IgG: the intravenous IgG paradox
Falk Nimmerjahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins
James N. Arnold et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
Andrew R. Crow et al.
BLOOD (2007)
Guidelines on the use of intravenous immune globulin for neurologic conditions
Tom Feasby et al.
TRANSFUSION MEDICINE REVIEWS (2007)
Fc gamma RIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin
Kyung-Hyun Park-Min et al.
IMMUNITY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations
Stephan von Gunten et al.
BLOOD (2006)
Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia
Andrew R. Crow et al.
PEDIATRIC BLOOD & CANCER (2006)
Mannan binding lectin and its interaction with immunoglobulins in health and in disease
James N. Arnold et al.
IMMUNOLOGY LETTERS (2006)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Common variable immune deficiency and autoimmunity
Daniel Brandt et al.
AUTOIMMUNITY REVIEWS (2006)
Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
JS Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Adverse events associated with intravenous immunoglobulin therapy
DJ Hamrock
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Differences between IGIV products: Impact on clinical outcome
EW Gelfand
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy
Y Hamaguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors
Y Kaneko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells
Vinayakumar Siragam et al.
NATURE MEDICINE (2006)
Fc gamma receptors: Old friends and new family members
F Nimmerjahn et al.
IMMUNITY (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
Intravenous immunoglobulin in immunodeficiency states - State of the art
E Toubi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
N Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
C Vaccaro et al.
NATURE BIOTECHNOLOGY (2005)
Common variable immunodeficiency:: the immune system in chaos
J Bayry et al.
TRENDS IN MOLECULAR MEDICINE (2005)
FcγRIV:: A novel FcR with distinct IgG subclass specificity
F Nimmerjahn et al.
IMMUNITY (2005)
Multi-dysfunctional pathophysiology in ITP
B Zhou et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions
KE Getman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
KM Dhodapkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immunoglobulin replacement therapy in primary antibody deficiency diseases - Maximizing success
A Durandy et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
V Siragam et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Human antibody - Fc receptor interactions illuminated by crystal structures
JM Woof et al.
NATURE REVIEWS IMMUNOLOGY (2004)
The complement system in regulation of adaptive immunity
MC Carroll
NATURE IMMUNOLOGY (2004)
Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult T-cell leukemia
ML Zhang et al.
CANCER RESEARCH (2004)
Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations
F Altznauer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis
M Butler et al.
GLYCOBIOLOGY (2003)
IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity
AR Crow et al.
BLOOD (2003)
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG
S Song et al.
BLOOD (2003)
Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease
P Bruhns et al.
IMMUNITY (2003)
IgG Fc receptor polymorphisms in human disease: Implications for intravenous immunoglobulin therapy
BA Binstadt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins:: a novel effector function of immunoglobulins
M Basta et al.
NATURE MEDICINE (2003)
Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells
AM Kalergis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Arthritis critically dependent on innate immune system players
H Ji et al.
IMMUNITY (2002)
Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia
JL Teeling et al.
BLOOD (2001)
High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
A Samuelsson et al.
SCIENCE (2001)
Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation
A Matsumoto et al.
JOURNAL OF BIOCHEMISTRY (2000)
Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcγ receptor III
L Fossati-Jimack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen:: A novel murine model for autoimmune glomerular basement membrane disease
A Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
